Illumina (ILMN)
(Delayed Data from NSDQ)
$94.66 USD
-8.05 (-7.84%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $94.98 +0.32 (0.34%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Illumina, Inc. has a market cap of $16.26B, which represents its share price of $102.71 multiplied by its outstanding shares number of 158.30M. As a large-cap company, ILMN's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ILMN 94.66 -8.05(-7.84%)
Will ILMN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ILMN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ILMN
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
ILMN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Other News for ILMN
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight
Illumina (ILMN) Surpasses Q2 Targets and Boosts 2025 Outlook
Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances
Illumina, Inc. 2025 Q2 - Results - Earnings Call Presentation